1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow DE-109 Intravitreal Injections (Open Label): new trials by email Literature Review of DE-109 Intravitreal Injections (Open Label) trials Research Report on DE-109 Intravitreal Injections (Open Label)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye DE-109 Intravitreal Injections, Sham Procedure, DE-109 Intravitreal Injections (Open Label) - Non Infectious Uveitis | Phase 3 | Terminated | Santen Inc. | 145 | 2018-11-19 | 2023-12-04 |
Santen Inc. (1)
Argentina (1) · India (1) · Italy (1) · United States (1)